Ingevity Corp
No enriched coverage for $NGVT in the last 7 days.
Ingevity Corp (NGVT) shares rose 19.2% YTD, outperforming its industry. The company's portfolio optimization, higher-margin businesses, and demand for hybrid vehicle applications drove growth. Q2 adjusted EBITDA increased 14% YoY to $115M, and 2026 guidance was raised to $380-$400M. NGVT holds a Zacks Rank #2 (Buy).
Li David H (President & CEO) sold 10,092 shares of Ingevity Corp (NGVT) at an average of $75.77 ($74.71–$75.83, $0.76M total) across 3 trades over 2026-08-14 to 2026-08-18 under a Rule 10b5-1 trading plan.
Li David H (President & CEO) sold 10,000 shares of Ingevity Corp (NGVT) at an average of $76.18 ($75.73–$76.62, $0.76M total) across 2 trades over 2026-08-12 to 2026-08-13 under a Rule 10b5-1 trading plan.
Recent NGVT coverage spans insider activity, earnings and corporate actions.
In the last 30 days, NGVT insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($386K). The most active reporter was Li David H, President & CEO, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Guidance lift suggests stronger earnings momentum, supporting a bullish outlook.
This is an insider sale, not a fundamental update, but it can modestly affect near-term sentiment and positioning.
This is a routine insider sale under a pre-arranged 10b5-1 plan, so it is more of a sentiment check than a fundamental change.
Raised guidance plus strong margin expansion and a PFAS municipal contract are likely to support near-term sentiment, but North America auto weakness and international volume declines are key offsets.
This is a routine insider sale with no stated 10b5-1 plan, but it does not disclose new company fundamentals.
AlphAI scores every news story that mentions NGVT with an AI model for sentiment and relevance, and aggregates insider trades from Ingevity Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Ingevity Corp (NGVT) shares rose 19.2% YTD, outperforming its industry. The company's portfolio optimization, higher-margin businesses, and demand for hybrid vehicle applications drove growth. Q2 adjusted EBITDA increased 14% YoY to $115M, and 2026 guidance was raised to $380-$400M. NGVT holds a Zacks Rank #2 (Buy).
2 min readLi David H (President & CEO) sold 10,092 shares of Ingevity Corp (NGVT) at an average of $75.77 ($74.71–$75.83, $0.76M total) across 3 trades over 2026-08-14 to 2026-08-18 under a Rule 10b5-1 trading plan.
2 min readLi David H (President & CEO) sold 10,000 shares of Ingevity Corp (NGVT) at an average of $76.18 ($75.73–$76.62, $0.76M total) across 2 trades over 2026-08-12 to 2026-08-13 under a Rule 10b5-1 trading plan.
1 min readIngevity (NGVT) held its Q2 2026 earnings call. Net sales were $314 million, down 5% on reported basis due to the Road Markings divestiture. Adjusted EBITDA rose 14% to $115 million, with margin at 36.6%. Adjusted EPS was $1.74. Free cash flow was $89 million. Full-year guidance for EBITDA and EPS was raised.
7 min readFisher Ryan C. (SVP, Gen. Counsel & Secretary) sold 2,709 shares of Ingevity Corp (NGVT) at an average of $73.72 ($73.67–$73.76, $0.20M total) across 2 trades on 2026-08-03.
1 min readIngevity (NYSE:NGVT) reported Q2 cash flow excluding a litigation settlement of about $89M, or $2.52/share, with capex near $10M. Performance Materials sales rose 4% to $161M, with segment EBITDA up 6% to $86M and margin to 53.6%. The company raised 2026 outlook to adjusted EBITDA $380M-$400M and EPS $5.00-$5.45, plus free cash flow $220M-$245M.
6 min readIngevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports second quarter 2026 financial results Second Quarter 2026 Results and Recent Highlights: • Net sales of $314.1 million decreased 5% from prior year; exc
6 min readIngevity Corp (NGVT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. ngvt-20260622 false Ingevity Corp 0001653477 0001653477 2026-06-22 2026-06-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 8-K _________________________________________________
3 min readDYER TERRANCE M (SVP, Chief HR Officer) sold 200 shares of Ingevity Corp (NGVT) at $68.53 on 2026-05-28.
2 min readDYER TERRANCE M (SVP, Chief HR Officer) sold 30 shares of Ingevity Corp (NGVT) at $68.57 on 2026-05-28.
2 min read
